Vanguard Group
IDXG

Vanguard Group’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-80,612
Closed -$253K 4380
2020
Q4
$253K Buy
80,612
+11,583
+17% +$36.4K ﹤0.01% 4064
2020
Q3
$213K Buy
69,029
+34,665
+101% +$107K ﹤0.01% 3951
2020
Q2
$160K Sell
34,364
-84,614
-71% -$394K ﹤0.01% 3946
2020
Q1
$616K Sell
118,978
-1,078,653
-90% -$5.58M ﹤0.01% 3625
2019
Q4
$599K Hold
1,197,631
﹤0.01% 3761
2019
Q3
$946K Buy
1,197,631
+32,945
+3% +$26K ﹤0.01% 3667
2019
Q2
$844K Buy
1,164,686
+700
+0.1% +$507 ﹤0.01% 3722
2019
Q1
$931K Buy
1,163,986
+267,422
+30% +$214K ﹤0.01% 3640
2018
Q4
$717K Buy
896,564
+36,054
+4% +$28.8K ﹤0.01% 3655
2018
Q3
$1.33M Sell
860,510
-5,462
-0.6% -$8.41K ﹤0.01% 3650
2018
Q2
$771K Buy
865,972
+112,696
+15% +$100K ﹤0.01% 3752
2018
Q1
$665K Buy
753,276
+72,383
+11% +$63.9K ﹤0.01% 3732
2017
Q4
$695K Buy
680,893
+546,368
+406% +$558K ﹤0.01% 3684
2017
Q3
$208K Buy
134,525
+68,708
+104% +$106K ﹤0.01% 3912
2017
Q2
$59K Buy
65,817
+19,238
+41% +$17.2K ﹤0.01% 4019
2017
Q1
$122K Buy
46,579
+33,546
+257% +$87.9K ﹤0.01% 3972
2016
Q4
$58K Sell
13,033
-236,978
-95% -$1.05M ﹤0.01% 4017
2016
Q3
$39K Sell
250,011
-10,000
-4% -$1.56K ﹤0.01% 4049
2016
Q2
$86K Hold
260,011
﹤0.01% 4039
2016
Q1
$65K Sell
260,011
-63,332
-20% -$15.8K ﹤0.01% 4060
2015
Q4
$161K Buy
323,343
+10,651
+3% +$5.3K ﹤0.01% 4037
2015
Q3
$559K Buy
312,692
+3,480
+1% +$6.22K ﹤0.01% 3818
2015
Q2
$443K Buy
309,212
+3,294
+1% +$4.72K ﹤0.01% 3898
2015
Q1
$413K Hold
305,918
﹤0.01% 3877
2014
Q4
$548K Sell
305,918
-8,404
-3% -$15.1K ﹤0.01% 3697
2014
Q3
$755K Sell
314,322
-1,400
-0.4% -$3.36K ﹤0.01% 3590
2014
Q2
$1.38M Hold
315,722
﹤0.01% 3394
2014
Q1
$1.45M Buy
315,722
+9,804
+3% +$44.9K ﹤0.01% 3342
2013
Q4
$1.47M Sell
305,918
-7,985
-3% -$38.4K ﹤0.01% 3310
2013
Q3
$1.51M Hold
313,903
﹤0.01% 3247
2013
Q2
$1.48M Buy
+313,903
New +$1.48M ﹤0.01% 3176